» Articles » PMID: 5041049

Comparative Cytogenetic Studies of the Influence of Phenylbutazone and Cyclophosphamide on Spermatogenesis in the Mouse

Overview
Journal Agents Actions
Specialty Pharmacology
Date 1972 Jun 1
PMID 5041049
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Embryolethality in the mouse following treatment of males with cyclophosphamide at specific germ cell stages.

Fritz H, Muller D, Hess R Agents Actions. 1973; 3(1):35-7.

PMID: 4715532 DOI: 10.1007/BF02023849.


Induced dominant lethals in female mice: effects of triaziquone and phenylbutazone.

Machemer L, Hess R Experientia. 1973; 29(2):190-2.

PMID: 4692764 DOI: 10.1007/BF01945469.


Cytogenetic effects of cyclophosphamide on mouse spermatogonia.

Rathenberg R Humangenetik. 1975; 29(2):135-40.

PMID: 1176135 DOI: 10.1007/BF00430350.


Cytogenetic study in spermatocytes of mice and Chinese hamsters after treatment with isoniazid (INH).

Adler I, Schmaltz A, Rathenberg R, Muller D, STRASSER F, Perret R Hum Genet. 1978; 42(1):50-4.

PMID: 649168 DOI: 10.1007/BF00291623.

References
1.
Muller D, STRASSER F . Comparative studies on the Chinese hamster bone marrow after treatment with phenylbutazone and cyclophosphamide. Mutat Res. 1971; 13(4):377-82. DOI: 10.1016/0027-5107(71)90049-2. View

2.
OAKBERG E . Duration of spermatogenesis in the mouse. Nature. 1957; 180(4595):1137-8. DOI: 10.1038/1801137a0. View

3.
SCHLEIERMACHER E . [On the effects of trenimon and endoxan on meiosis in male mice. II. Cytogenetic findings after treatment with trenimon and endoxan]. Humangenetik. 1966; 3(2):134-55. DOI: 10.1007/BF00291295. View

4.
SCHLEIERMACHER E, SCHROEDER T, Adler I, Vrba M, Vogel F . [Chemically induced mutations in mammals and man. In vivo and in vitro cytogenetic studies]. Dtsch Med Wochenschr. 1967; 92(51):2343-50. DOI: 10.1055/s-0028-1106145. View

5.
Baldermann K, ROHRBORN G, SCHROEDER T . [Mutagenicity tests with trypaflavin and hexamethylenetetramine in mammals in vivo and in vitro]. Humangenetik. 1967; 4(2):112-26. DOI: 10.1007/BF00291255. View